Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial

BACKGROUD: The European Organization for Research and Treatment of Cancer (EORTC) trial 22,911 reported 74% 5-year biochemical disease-free survival (bDFS) in patients with prostate carcinoma treated with radical prostatectomy (RP) followed by postoperative radiotherapy (RT). This study aimed to imp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Prostate Cancer Prostatic Dis
Glavni autori: Mantini, Giovanna, Siepe, Giambattista, Alitto, Anna Rita, Buwenge, Milly, Nguyen, Nam P., Farioli, Andrea, Schiavina, Riccardo, Catucci, Francesco, Deodato, Francesco, Fionda, Bruno, Frascino, Vincenzo, Macchia, Gabriella, Ntreta, Maria, Padula, Gilbert D. A., Arcelli, Alessandra, Cammelli, Silvia, Rambaldi, Giuseppe Zanirato, Cilla, Savino, Valentini, Vincenzo, Morganti, Alessio G.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283858/
https://ncbi.nlm.nih.gov/pubmed/30038390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-018-0064-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items